Similarly, Strohecker et al. showed that the deletion of Atg7 in mice expressing an activating mutation of B-Raf (BrafV600E/+) promotes early tumor development in the lung but also inhibits the progression to a more malignant phenotype and increases mouse survival [74]. This evidence concerns the gene ATG7 and neoplasm.